A Phase Ii International, Multicenter Study of Oral Panobinostat (lbh589) in Patients With Refractory Cutaneous T-cell Lymphoma (ctcl)
(2008) 13th Congress of the European-Hematology-Association — Location: Copenhagen(Denmark) (12.June.2008)
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Bernengo, M. G., Vanaclocha, F., Duvic, M., Kuzel, T., Kerdel, F., Pinter-Brown, L., Bosly, A., Okada, C., Breneman, D., Zinzani, P. L., Becker, J., Hughey, L., Ardaiz, M., Zain, J., Zhang, L., Hirawat, S., Laird, G., Johnson, D., & Prince, H. M. (2008). A Phase Ii International, Multicenter Study of Oral Panobinostat (lbh589) in Patients With Refractory Cutaneous T-cell Lymphoma (ctcl). Haematologica : the hematology journal, 93, 109. https://hdl.handle.net/2078.5/68842 (Original work published 2008)